Acea Therapeutics, Inc.
Records under this name other than the patents Acea Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 18 patents it holds.
Showing 1 to 3 of 3 · Back to Acea Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,851,657 | Synthetic Process for Anticancer Drug Fluorapacin and Trisulfide Derivatives Lapsed on the fee record Ended Dec 14, 2022 · High confidence | Lapsed on the fee record | Ended Dec 14, 2022 | High confidence |
| US 7,622,507 | Substituted Organosulfur Compounds and Methods of Using Thereof Lapsed on the fee record Ended Nov 24, 2021 · High confidence | Lapsed on the fee record | Ended Nov 24, 2021 | High confidence |
| US 8,334,316 | Substituted Organosulfur Compounds and Methods of Using Thereof Lapsed on the fee record Ended Dec 18, 2020 · High confidence | Lapsed on the fee record | Ended Dec 18, 2020 | High confidence |